We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s estimated up to 125 million people will have the con.....
Read more

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes. The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due to peripheral arterial disease. Alarmingly, an estimated eight p.....
Read more

A collection of researchers will develop their skills and establish crucial new collaborations following generous funding through the Skipper Charitable Trust. Six researchers have received a 2024 Beryl and Jack Jacobs Travel Award, enabling them to travel for conferences and work with experts across the globe. Academic Director Professor James Elliott was thrilled to announce the successful recipi.....
Read more

One of our impressive researchers has taken out a prestigious national award to broaden treatment options for diabetes. Despite tough competition, Cameron Evans from the Cardiovascular Discovery Group has been awarded the 2024 Australian Centre for Accelerating Diabetes Innovation (ACADI) PhD grant. The funding means Cameron will be able to progress his research investigating the use of a new medic.....
Read more

A large group of inspiring researchers delivered presentations at the inaugural Kolling Institute Symposium, highlighting the strength of research underway at the institute. Close to a hundred people attended the event at the Northside Conference Centre focusing on the key themes of collaboration, innovation and wellbeing. Senior researchers and up-and-coming investigators took to the stage, outlin.....
Read more

At the Kolling Institute, we are tremendously fortunate to work with so many skilled and dedicated researchers. Our Kolling video gives you an insight into some of our latest research and our inspirational teams. Click here to view:
Read more